Globe Life Inc. (NYSE:GL) Given Average Rating of “Moderate Buy” by Analysts

Shares of Globe Life Inc. (NYSE:GL) have been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $152.7778.

A number of research analysts have recently weighed in on the company. Keefe, Bruyette & Woods raised their price objective on Globe Life from $145.00 to $155.00 and gave the company an “outperform” rating in a research report on Monday, July 28th. Weiss Ratings restated a “buy (b-)” rating on shares of Globe Life in a research report on Saturday. BMO Capital Markets restated a “market perform” rating and set a $149.00 price objective (up previously from $114.00) on shares of Globe Life in a research report on Wednesday, July 30th. Cfra Research upgraded Globe Life to a “moderate buy” rating in a research report on Friday, July 25th. Finally, JPMorgan Chase & Co. raised their price objective on Globe Life from $145.00 to $160.00 and gave the company an “overweight” rating in a research report on Tuesday, July 8th.

Insider Activity

In other news, CFO Thomas Peter Kalmbach sold 28,952 shares of the firm’s stock in a transaction that occurred on Tuesday, July 29th. The stock was sold at an average price of $140.97, for a total value of $4,081,363.44. Following the completion of the sale, the chief financial officer directly owned 30,665 shares of the company’s stock, valued at $4,322,845.05. This trade represents a 48.56% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael Clay Majors sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $137.41, for a total value of $1,374,100.00. Following the completion of the sale, the executive vice president directly owned 47,066 shares of the company’s stock, valued at $6,467,339.06. The trade was a 17.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 51,452 shares of company stock valued at $7,222,713 in the last ninety days. Insiders own 1.97% of the company’s stock.

Institutional Investors Weigh In On Globe Life

Several institutional investors have recently modified their holdings of the stock. Invesco Ltd. lifted its stake in shares of Globe Life by 3.9% in the 2nd quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock valued at $487,396,000 after purchasing an additional 147,644 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Globe Life by 2.9% during the second quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock valued at $339,875,000 after buying an additional 76,995 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Globe Life by 9.3% during the first quarter. Dimensional Fund Advisors LP now owns 1,741,131 shares of the company’s stock valued at $229,323,000 after buying an additional 148,397 shares during the period. AQR Capital Management LLC boosted its position in shares of Globe Life by 98.6% during the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after buying an additional 696,548 shares during the period. Finally, Norges Bank purchased a new position in shares of Globe Life during the second quarter valued at approximately $157,722,000. 81.61% of the stock is owned by institutional investors.

Globe Life Trading Down 1.5%

Shares of Globe Life stock opened at $133.67 on Monday. The firm has a market cap of $10.83 billion, a price-to-earnings ratio of 9.69 and a beta of 0.55. The business has a 50-day moving average price of $139.54 and a 200-day moving average price of $129.62. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43. Globe Life has a twelve month low of $100.27 and a twelve month high of $147.83.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, October 22nd. The company reported $4.81 earnings per share for the quarter, beating analysts’ consensus estimates of $4.54 by $0.27. The firm had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.52 billion. Globe Life had a return on equity of 22.12% and a net margin of 19.36%.During the same quarter last year, the business posted $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. Equities research analysts anticipate that Globe Life will post 13.87 EPS for the current fiscal year.

Globe Life Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be given a dividend of $0.27 per share. The ex-dividend date is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. Globe Life’s dividend payout ratio is 7.83%.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.